Biodefense Shares Surge as Russian Lab Worker's Death Sparks Health Concerns
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Shares of several vaccine manufacturers have also jumped after a worker at a plague research lab in Russia died.
Novavax and Moderna Stocks Rally After Russia Plague Scare
TLDR A 28-year-old lab worker at Russia’s Irkutsk Anti-Plague Research Institute died after developing pneumonia of unknown origin following suspected plague exposure. Novavax jumped 20%, Moderna rose 7%, Emergent BioSolutions gained 14% and Arcturus Therapeutics climbed 13% in Monday’s regular...
Dozens of people have been quarantined in Russia after a death at a research laboratory, and the news immediately triggered a wave of speculative buying on the stock market. Small investors, following proven scenarios during previous pandemics, stormed the shares of vaccine and biodefense companies, hoping that the companies would soon receive lucrative government orders, Telex wrote.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
